Quality of Life in Second‐Line Treatment of Metastatic Castration‐Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment Registry
暂无分享,去创建一个
D. Betticher | C. Rentsch | F. Stenner | R. Cathomas | S. Rothschild | R. Popescu | R. Morant | D. Rauch | C. Caspar | R. Zenhäusern | U. Huber